Virtual Reality for ADHD
Trial Summary
What is the purpose of this trial?
The goal of this pilot randomized clinical trial is to test the impact of a virtual reality program for improving the ability of emerging adults (age 18-25) with attention deficit hyperactivity disorder (ADHD) to stay focused while completing homework and studying. This study compares the impact of using a virtual reality headset to using a virtual reality headset while also receiving feedback about levels of focus to a control group. The main question is whether participants demonstrate significantly improved concentration while completing homework and studying in virtual reality and whether they enjoy and prefer working in a virtual reality environment. Concentration is measured both through participant report and also using keyboard and mouse click data to assess work productivity objectively.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications. It is best to consult with the trial coordinators for specific guidance.
What data supports the effectiveness of the treatment Meta Quest 3 VR Headset for ADHD?
Is virtual reality safe for children with ADHD?
How does the Meta Quest 3 VR Headset treatment for ADHD differ from other treatments?
The Meta Quest 3 VR Headset treatment for ADHD is unique because it uses virtual reality to create realistic environments that help assess and improve attention and cognitive functions. Unlike traditional methods, this approach provides an immersive experience that can simulate real-world distractions, potentially offering a more engaging and effective way to manage ADHD symptoms.138910
Research Team
Joshua M Langberg, PhD
Principal Investigator
Rutgers University
Eligibility Criteria
This trial is for young adults aged 18-25 with ADHD. Participants should be currently enrolled in an educational program and have regular homework or study tasks. They must not have any conditions that would interfere with VR headset use, such as severe motion sickness or epilepsy.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Participants complete a 2-session baseline where they complete homework and study without using the VR headset
Treatment
Participants use the VR headset in their room/home or the library 10 times over two weeks for 1-hour sessions each time
Follow-up
Participants are monitored for concentration, effort, and motivation, and answer questions about VR feasibility, usability, and acceptability
Treatment Details
Interventions
- Meta Quest 3 VR Headset (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rutgers, The State University of New Jersey
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator
Louisiana State University Health Sciences Center in New Orleans
Collaborator